Global Generic Drugs Market

Generic Drugs Market Size, Share, Growth Analysis, By Route of Administration (Oral, Parenteral), By Therapeutic Application (Cardiovascular Disorders, Central Nervous System (CNS) Disorders), By Formulation, By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35J2094 | Region: Global | Published Date: December, 2025
Pages: 157 |Tables: 65 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Generic Drugs Market size was valued at USD 0.68186 Billion in 2024 and is poised to grow from USD 0.75 Billion in 2025 to USD 1.58 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026–2033).

    The situation in the generic drugs industry is very competitive because of the presence of large number of players focusing on cost efficiency and market penetration. There are several leading companies who are the major market dominators due to their large product lines and global presence. These organizations possess strong manufacturing possibilities and perform a number of strategic partnerships to retain their position. In addition, the existence of considerable numbers of new players and local manufacturers in the developing regions such as Asia-Pacific lead to the necessity to compete. It is also significant to remember that new medications become harder to launch as off-patent originator products because they are more difficult to develop, produce, and sell. 'Sandoz - Switzerland ', 'Teva Pharmaceuticals - Israel ', 'Sun Pharmaceutical Industries Ltd. - India ', 'Viatris Inc. - USA ', 'Fresenius Kabi AG - Germany ', 'Cipla Ltd. - India ', 'Dr. Reddy's Laboratories Ltd. - India ', 'Lupin Limited - India ', 'Aspen Pharmacare Holdings Limited - South Africa ', 'Zydus Cadila - India ', 'KRKA d.d. - Slovenia ', 'Towa Pharmaceutical Co., Ltd. - Japan ', 'STADA Arzneimittel AG - Germany ', 'Glenmark Pharmaceuticals Ltd. - India ', 'Amneal Pharmaceuticals, Inc. - USA ', 'Biocon Limited - India ', 'Aurobindo Pharma Ltd. - India ', 'Sawai Pharmaceutical Co., Ltd. - Japan ', 'Torrent Pharmaceuticals Ltd. - India ', 'Hikma Pharmaceuticals PLC - UK'

    As of 2021, there were more than 10.1 million cases of cancer in men and 9.3 million cases in women. In addition, there were over 350 million people diagnosed with arthritis worldwide and the number is expected to grow as a result of the increase of the elderly population. Increasing prevalence of chronic diseases is expected to add to the need for quality health services, which would result in the generic drugs market growth across the forecast period.  

    Growing Production and Consumption of Generic Drug in India: As one of the top pharmaceutical markets in the world, India hosts several of the world’s leading pharma companies. India’s pharma industry lauded as 3rd in the world by volume and 14th by value, according to Invest India, India’s official agency for Investment Promotion and Facilitation, and has more than 3,000 pharmaceutical companies and over 10,500 factories. Additionally, India boasts the most US-FDA approved pharma plants outside of the US. 

    North America accounts for the largest demand generic drug market share in terms of revenue with the US generic drug market being a major demand hub in the region. The US is the home to some of the major pharmaceutical companies such as Pfizer Inc., Merck and Co. Inc., and Amgen Inc. Pharmaceutical giants are influencing both physicians and patients through a varied range of specialized products. The demand in North America is high due to key factors such as spike in chronic liver diseases, drastic change in the lifestyles and increased consumption of alcohol and tobacco in the US. Canada is witnessing rising demand for biosimilars, driven by increasing cases of breast cancer. 

    Related Reports

    Specialty Generics Market
    Buy Now GET FREE SAMPLE
    Prescription Drugs Market
    Buy Now GET FREE SAMPLE
    Pharmaceuticals Market
    Buy Now GET FREE SAMPLE
    Over The Counter Drugs Market
    Buy Now GET FREE SAMPLE
    Pharmacy Market
    Buy Now GET FREE SAMPLE
    Active Pharmaceutical Ingredients (API) Market
    Buy Now GET FREE SAMPLE
    Orphan Drug Market
    Buy Now GET FREE SAMPLE
    Drug Discovery Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Generic Drugs Market

    Report ID: SQMIG35J2094

    $5,300
    BUY NOW